Flexus Biosciences engages in developing and commercializing therapeutics for cancer diseases.
Business Model:
Revenue: $3M
Employees: 11-50
Flexus Biosciences was acquired by
Bristol Myers Squibb.
The acquisition happend on 2015-02-23.
Details of the transaction were not public
Address: 75 Shoreway Rd
City: San Carlos
State: CA
Zip: 94070
Country: US
Flexus Biosciences engages in developing and commercializing therapeutics for cancer diseases.
Contact Phone:
+16504899000
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 3/2015 | Venture Round | 1 | $15.2M |
Kleiner Perkins Kleiner Perkins Kleiner Perkins Kleiner Perkins |
12/2014 | Series B | $25M |
The Column Group Kleiner Perkins Caufield & Byers Celgene Corporation |
10/2013 | Equity | $15.2M |
Kleiner Perkins Caufield & Byers |
12/2014 | Series B | 3 | $38M |
Kleiner Perkins The Column Group Celgene Kleiner Perkins Kleiner Perkins The Column Group Celgene Kleiner Perkins |
10/2013 | Series A | 1 | $13M |
Kleiner Perkins Kleiner Perkins Kleiner Perkins Kleiner Perkins |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|